Diet on tirzepatide means the eating, drinking and fluid habits that go with the drug, which FDA approved for weight management alongside a reduced-calorie diet and more physical activity.
Alcohol: what the label covers and what it leaves out
We read the Zepbound Medication Guide for any mention of drinking. There is none; "alcohol" appears only as benzyl alcohol, an inactive ingredient in the multi-dose vial and KwikPen [1]. The label's drug interaction section names insulin and drugs that raise insulin, oral medicines in general and birth control pills; alcohol is not among them [3].
Two label warnings are worth raising with your prescriber before you drink. First, low blood sugar: rare without diabetes, but 10.3% of people with type 2 diabetes who also took a sulfonylurea had it in the Zepbound trial [3]. Second, dehydration: vomiting and diarrhea can drain fluids and may lead to kidney problems [1]. None of our sources studies whether tirzepatide changes alcohol cravings.
Eating on tirzepatide
Zepbound is approved for use together with a reduced-calorie diet and more physical activity [2]. The trial results were produced under that approval, so they do not tell you what happens if you skip the diet or exercise. You can take your shot with or without food [1], so there is no need to eat first.
The label sets no calorie number, no protein number, no list of foods to avoid and no vitamin plan. Our research did not find a label or trial source that does, so ask your prescriber or a registered dietitian for targets. One number shows why protein comes up so often: in a SURMOUNT-1 substudy, about a quarter of the weight lost on tirzepatide was lean mass [4]. Practical plans are on GLP-1 diet plan and how to keep muscle on a GLP-1.
When you are not hungry
Tirzepatide acts on appetite and slows stomach emptying [3], so smaller appetites are expected. Nausea is the most common side effect, reported by 25% to 29% on Zepbound vs 8% on placebo [3]. If nausea, vomiting or diarrhea does not go away, call your prescriber [1]. More on tirzepatide side effects.
Can you eat whatever you want?
The label describes tirzepatide as reducing appetite and food intake, not as cancelling out what you eat [3]. It is approved as part of a reduced-calorie plan [2]. Questions about ketosis or sugar cravings on tirzepatide are not addressed in our sources.
Water, coffee and other drinks
The Medication Guide says to drink fluids to help lower the chance of dehydration, and to tell your prescriber right away about nausea, vomiting or diarrhea that does not go away [1]. It gives no number of glasses or ounces. Coffee, caffeine, diet soda and milk are not named in the label's drug interaction section [3].
Does tirzepatide lower blood sugar?
Yes. Mounjaro, the diabetes brand, is approved to improve blood sugar in type 2 diabetes [5]. In the Zepbound trial of adults with type 2 diabetes, HbA1c fell 2.1 points on 10 mg and 15 mg vs 0.5 on placebo. In adults without diabetes, whose average HbA1c was 5.6%, it fell 0.4 vs 0.1 [3].
Low blood sugar (under 54 mg/dL) was rare without diabetes: 0.3% vs 0% on placebo. With type 2 diabetes it was 4.2% vs 1.3% [3]. The label tells prescribers to consider lowering insulin or sulfonylurea doses when tirzepatide starts [3]. Interactions are covered on tirzepatide interactions.
Signs of low blood sugar
Dizziness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety or mood changes, hunger, weakness or feeling jittery [1]. Treat it as your care team has told you, and call 911 if someone is confused, passes out or cannot swallow.
Compounded tirzepatide with added vitamins
Some compounded products add vitamins to tirzepatide. In a September 18, 2026 warning letter to Empower Pharmacy, a large compounding pharmacy, FDA called tirzepatide/niacinamide products "essentially copies" of approved drugs and questioned how the claimed patient-specific need was documented [6]. Compounded tirzepatide is not FDA-approved, and FDA does not review it for safety, effectiveness or quality [7]. A vitamin added to a vial is not a nutrition plan. Read compounded tirzepatide and the FDA warning letter tracker.
Results with and without diet changes
Trial averages, such as 20.9% weight loss at 72 weeks on 15 mg in SURMOUNT-1 [8], come from people using the drug with diet and activity changes. See tirzepatide results for the full numbers.
Questions people ask
Can you drink alcohol while taking tirzepatide?
What should I eat on tirzepatide?
The label sets no food list. Zepbound is approved for use with a reduced-calorie diet and more physical activity [2]. Ask your prescriber or a registered dietitian for a plan.
Should I take tirzepatide with food?
It does not matter. The label says tirzepatide can be taken with or without food, at any time of day [1].
How much water should I drink on tirzepatide?
The label gives no number. It says to drink fluids to lower the chance of dehydration and to call your prescriber if nausea, vomiting or diarrhea does not go away [1].
How much protein should I eat on tirzepatide?
The FDA label sets no protein target. In a SURMOUNT-1 substudy, about a quarter of weight lost was lean mass [4], so ask your prescriber or a dietitian for a target that fits you.
Can tirzepatide cause low blood sugar in people without diabetes?
Rarely. In the Zepbound trial of adults without diabetes, low blood sugar under 54 mg/dL occurred in 0.3% on tirzepatide vs 0% on placebo [3].
Does tirzepatide lower blood sugar?
Can I drink coffee on tirzepatide?
Coffee and caffeine are not named in the label's drug interaction section, which lists insulin and insulin secretagogues, oral medicines and birth control pills [3].
Can you lose weight on tirzepatide without dieting?
The trials tested tirzepatide under an approval for use with a reduced-calorie diet and more physical activity [2], so they do not show results without those changes.
What vitamins should I take with tirzepatide?
The FDA label recommends no vitamins. Compounded vials with added vitamins are not FDA-approved; FDA called tirzepatide/niacinamide products "essentially copies" in a September 2026 warning letter [6].
Sources
8 cited
- Zepbound Medication Guide and Patient Information. DailyMed, U.S. National Library of Medicine, Aug 28, 2026.
- Zepbound (tirzepatide) label, revised 8/2026. DailyMed, U.S. National Library of Medicine, Aug 28, 2026.
- Zepbound (tirzepatide) prescribing information, revised 04/2026. U.S. Food and Drug Administration, Apr 2026.
- SURMOUNT-1 body composition substudy abstract (Look et al., 2025). Diabetes, Obesity and Metabolism, via PubMed, Feb 25, 2025.
- Mounjaro (tirzepatide) label, revised 8/2026. DailyMed, U.S. National Library of Medicine, Aug 27, 2026.
- Warning letter to Empower Clinic Services LLC dba Empower Pharmacy. U.S. Food and Drug Administration, Sep 18, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- SURMOUNT-1 trial abstract (Jastreboff et al., NEJM 2022). New England Journal of Medicine, via PubMed, Jun 4, 2022.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.